Drugs: UK Trade with EU

(asked on 26th November 2020) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect on the pharmaceutical industry of a mutual recognition agreement on (a) good manufacturing practice and (b) batch certification not being agreed by EU and the UK.


Answered by
Nadine Dorries Portrait
Nadine Dorries
This question was answered on 3rd December 2020

Both the European Union and the United Kingdom are committed to agreeing a future partnership by the end of 2020 and are working to achieve this.

In the event of an agreement not being reached with the EU, the UK will continue to recognise certification issued from European Economic Area (EEA) countries confirming compliance with the standards of good manufacturing practice and also accept batch testing done from EEA countries for a period of two years after the end of the transition period, until 1 January 2023. This will provide time for industry to adapt supply chains to future UK regulatory requirements.

Reticulating Splines